Pelat, Michel <br/><br/>
Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo.  [electronic resource] 

 -  Circulation  May 2003 
 - 2480-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.CIR.0000065601.83526.3E  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aorta--drug effects<br/>Apolipoproteins E--deficiency<br/>Autonomic Nervous System--physiopathology<br/>Blood Pressure--drug effects<br/>Blood Pressure Monitoring, Ambulatory<br/>Caveolin 1<br/>Caveolins--metabolism<br/>Cholesterol--blood<br/>Chronobiology Disorders--complications<br/>Electrocardiography, Ambulatory<br/>Fluorobenzenes--pharmacology<br/>Heart Rate--drug effects<br/>Hyperlipidemias--complications<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Myocardium--metabolism<br/>Nitric Oxide--metabolism<br/>Nitric Oxide Synthase--metabolism<br/>Nitric Oxide Synthase Type II<br/>Nitric Oxide Synthase Type III<br/>Pyrimidines<br/>Rosuvastatin Calcium<br/>Sulfonamides<br/>Treatment Outcome